SAN JOSE, Calif., March 18, 2019 /PRNewswire/ -- BioPharmX Corporation BPMX, a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced presentations at multiple upcoming investor conferences.
President and CEO Dr. David S. Tierney will present the latest company overview at:
- The 31st Annual ROTH Conference on Monday, March 18 at 8:30am Pacific Time in Laguna Niguel, CA.
- The Oppenheimer 29th Annual Healthcare Conference on Wednesday, March 20, 2019 at 1:00pm Eastern Time in New York, NY.
About BioPharmX® Corporation
BioPharmX Corporation BPMX is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX™ Topical Delivery System for dermatology indications. To learn more about BioPharmX, visit www.BioPharmX.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/biopharmx-to-participate-in-the-31st-annual-roth-conference-and-the-oppenheimer-29th-annual-healthcare-conference-300813694.html
SOURCE BioPharmX Corporation
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.